Energy Manager
2 weeks ago
Yes, could be some interest brewing from the shows, or the fact that both Presidential candidates are now pushing for legalization of marijuana in the US. President Trump is now all-in on the rescheduling, and legalization of marijuana, and will be voting to legalize marijuana in his home state of Florida. Statistics show that more people use marijuana daily than alcohol, and this number will only continue to grow as more and more states legalize it. The important thing to remember is that as marijuana becomes legal in more states across America, and in other countries - it will never be legal to drive while impaired by alcohol, or any drug, legal, illegal, or even over the counter drugs. This includes cannabis.
The timing of the Beta testing for Lifeloc's device could not be better positioned, as the marijuana sector builds momentum going into the November election. Hopefully this will coincide simultaneously, and we will see a growing interest in Lifeloc's common stock, as state or local police forces start testing the device in real life situations. Lifeloc has stated that they have Beta testing in place, and are looking to add more agencies to the list for additional testing - which is expected to begin this year.
pdicamillo1
3 weeks ago
From Lifeloc's LinkedIn:
Visit Lifeloc at Booth #216
Stop by for a demo of the LT7 portable breath alcohol tester and the EASYCALG2 Automatic Calibration Station.
Lifelocβs breath alcohol testers cover the full spectrum of police use from economical alcohol screeners to portable roadside evidential devices provisioned with printers. All devices come standard with both passive and direct testing and depending on the unit include a variety of features. These features incl extensive test memory, wireless keyboard and printing, remote web-based diagnostics, and software tailored to the specific needs of your agency.
When used with the Lifeloc EASYCALG2® station, the FC and L Series instruments offer fully automatic calibration, calibration verification and record keeping functionality whether in the field or the lab.
Lifeloc's portable breath analyzers are US manufactured, CE marked and NHTSA approved as evidential instruments. International certifications are available
pdicamillo1
3 weeks ago
"The additional disc Parameters can open the device to a much broader scope of testing capability in the future":
Can we please add MPOX diagnostic tests to the list:
https://www.who.int/news/item/29-08-2024-who-urges-rapid-access-to-mpox-diagnostic-tests--invites-manufacturers-to-emergency-review
"Expanding access to diagnostic services is urgently needed as tests are essential to critical measures such as strengthened laboratory capacity, improved case investigation, contact tracing, surveillance data collection, and timely reporting. As a package, these help countries identify chains of transmission, detect cases early, prevent further spread, and monitor the virus in real-time. The establishment of Emergency Use Listing procedures for mpox diagnostic tests will help advance towards this goal."
pdicamillo1
4 weeks ago
From the recent IACP (Impaired Driving & Traffic Safety Conference) that Lifeloc attended on Aug. 16th-18th:
Innovating Roadside Alcohol & Drug Testing
Lifeloc Technologies recently attended the IACP IDTS Conference in Washington DC where we had the opportunity to showcase our latest products and innovations. Our team had the pleasure of demonstrating our full line of breath alcohol testers, which are widely used by law enforcement agencies nationwide. In addition, we discussed our upcoming saliva drug testing device which generated significant interest from attendees. We are excited to announce that we will begin initial beta testing later this year, specifically testing for delta-9-THC, the primary psychoactive substance in cannabis. Our team appreciated the positive feedback and interest from attendees; we welcome any agencies interested in being added to our beta testing list to contact us.
At Lifeloc Technologies, our commitment to advancing and enhancing testing solutions reflects our dedication to public safety and effective enforcement. We look forward to continuing to innovate and support the vital work of law enforcement agencies across the country. Lifelocβs SpinDX technology for detecting delta-9-THC in saliva could be a significant step forward in drug testing and enforcement.
Stay tuned for updates on our progress and the release of Lifelocβs drug testing device.
pdicamillo1
1 month ago
Update on the Lifeloc SpinDx Patent Info:
The US patent office routinely publishes applications 18 months after the application priority date, which in this case was the filing of the provisional patent in February 2023. The publication of the application has no bearing on the grant of the patent, and this patent has not yet been granted. I do not believe the publication of the application really is noteworthy and so there is no press release on it. The publication of the application does give us a little more freedom to talk without the worry of releasing too much confidential information, as the whole application is now available publicly.
We have not yet received any communication from the patent office regarding the acceptance of this application, and with their typical timelines, probably will not hear anything before next year.
Receiving a grant of this patent certainly will be a news worthy event.
Energy Manager
1 month ago
After looking into it further, it looks like NIST is working with the University, not in conjunction with any company, but to support the industry as a whole. NIST is an agency within the US Dept. of Commerce, that, in part, works to advance measurement science, standards, and technology, to promote industrial competitiveness, and improve quality of life.
They see the need to standardize the measurement of THC in Breath Samples, and are working to provide the science and measurement standards for a reliable way to validate testing in breath samples. Simply put, they have Lifeloc's back. It's a government agency, working to prove the validity of testing for THC in the breath, which they say, may take a couple of years...
In the meantime, Lifeloc was on the correct path, by focusing on saliva based testing, which is now becoming widely adapted, and the testing method of choice for our current time. As NIST works in the background, Lifeloc can continue to adapt their technology to utilize breath samples vs saliva, after they have commercialized the SpinDx, saliva based test.
Energy Manager
1 month ago
The need for a device to detect recent THC use is evident, and lawmakers, and our government want to bring it to fruition as soon as possible. More news, this time, much closer to home - working with the University of Colorado. Lifeloc is currently working with the University of Colorado, in testing of human subjects with their SpinDx device, so something tells me that there may be some sort of collaboration here ?
https://www.marijuanamoment.net/federal-researchers-explore-paradigm-changing-approach-to-detect-recent-marijuana-use-through-breath-tests/?
Energy Manager
1 month ago
They have been traditionally slow to release pertinent information, if at all, until their quarterly reports. I have a feeling this may soon change, as their device nears completion. I only found the patent info by chance, a few minutes before the market close. Maybe we will here something early net week, which would be better than a Friday afternoon anyway.
It is a valuable piece of information, and should be treated as material news, and a press release should be issued in my opinion.
Energy Manager
1 month ago
Good question. I'm sure that if it was not covered under the current licensing agreement, that Sandia would be open to discussing further applications. I think it's important to not get too excited about future diagnostics, and focus on the goal at hand, which is the development for drugs of abuse, firstly, THC.
I do find the inclusions that were listed, are very intriguing, and could be very valuable in the future. Lifeloc has it in their "back pocket," for now, and everything is starting to fall into place, and we, as early investors, should find this very exciting...!
Energy Manager
1 month ago
Not sure about cancer and diabetes, although there has been studies done on early detection from breath samples. I think the value of the device, is that it will be able to give immediate, non-invasive results for the items listed in the patent app.. This can prove to be invaluable to first responders, in sporting events, bodybuilding competitions, mass outbreaks of GI or Respiratory Dx, pandemics as we witnessed with COVID, etc...
pdicamillo1
1 month ago
From the original licensing agreement between Lifeloc and Sandia, it allows Lifeloc to develop and market the SpinDx technology to detect drug abuse.
How does this fit into the other applications of food and water safety, medical diagnostics, illness, performance enhancing drugs, bio-agent detection, etc.
pdicamillo1
1 month ago
This makes it sound like the SpinDx device becomes infinitely more valuable. They are talking about detecting illness, disease, infections, performance enhancing drugs, food borne issues, etc.
Any chance that the device could detect the early onset of cancer, diabetes, etc. from the results on the disk?
You would have to think multiple companies would have an interest in this type of detection device.
Energy Manager
1 month ago
The additional disc Parameters can open the device to a much broader scope of testing capability in the future - such as immediate, on site testing for anabolic steroid use - Stanozolol and Oxandrolone, respiratory diseases and viruses - including COVID, gastrointestinal infections from E Coli, Listeria, and Salmonella, etc...
Although this is not the immediate scope of intention for the device, which is currently focused on detection of THC, and secondly, detection of other drugs of abuse, including Fentanyl, Meth, and Cocaine, it gives them the ability, and protection from a provisional patent, to expand their product line vastly in the future...
Energy Manager
1 month ago
Patents almost always add value to a company in many ways. A patent application basically is a precursor to the actual patent. It gives the company a quick way to protect the invention for a year, while they put the finishing touches - testing, etc on the device. Basically a "Patent Pending" status. This about locks it up for Lifeloc, and it's intellectual property - giving Lifeloc a proprietary advantage over all of it's competitors.
I find the items I have copied from the Patent Application very, very valuable in my opinion...
9. The centrifugal micro-fluidic disk of claim 1, wherein one of the array of chemical detection sectors is a delta-9-THC detection sector.
10. The centrifugal micro-fluidic disk of claim 1, wherein the array of chemical detection sectors includes one or more of cocaine, methamphetamine, and fentanyl detection sectors.
11. The centrifugal micro-fluidic disk of claim 1, wherein the array of chemical detection sectors includes one or more of oxandrolone, stanozolol, and erythropoietin detection sectors.
12. The centrifugal micro-fluidic disk of claim 1, wherein the array of chemical detection sectors includes one or more of E. coli O157:H7, Listeria spp., and Salmonella spp. detection sectors.
13. The centrifugal micro-fluidic disk of claim 1, wherein the array of chemical detection sectors includes one or more of Streptococcus pneumoniae, Respiratory Syncytial Virus, and COVID-19 detection sectors.
14. The centrifugal micro-fluidic disk of claim 1, wherein the array of chemical detection sectors includes human or veterinary health diagnostic detection sectors.
Energy Manager
1 month ago
In the News...
βThere are now more options for officers to test for cannabis, and as a result, this has led to an increase in the detection of drug-impaired drivers.β Mathew Austin, Saskatchewan Highway Patrol
The majority (65%) of carriers and drivers surveyed have indicated they would prefer an industry-wide shift toward a test that indicates recent marijuana use (for example, the day before) instead of the current test that can identify earlier marijuana use.
There are different testing methods, and currently, in Canada, urine and oral fluid tests play roles in identifying recent versus past drug use. Davids explained that urine tests, for instance, detect substances over a longer period.
Meanwhile, oral fluid tests β which have been gaining increased popularity β are more effective in identifying recent use, particularly for THC, within the last 12 to 24 hours. Meanwhile, hair testing is not widespread since it detects cannabis use within one to three months, and blood tests are considered too invasive.
Driver Check, for example, uses oral fluid and urine tests to determine drug use.
https://www.trucknews.com/health-safety/canada-sees-steady-trends-in-marijuana-positive-tests-among-truck-drivers-since-legalization/1003187827/
Energy Manager
2 months ago
In the first six months of 2024 we purchased SpinDx related test and other equipment totaling $64,249 and in 2023 $0. In addition, during the first six months of 2024 we invested $227,354 in space required for SpinDx related work that is not yet in service. We are estimating that completing and equipping this lab space will require an additional $300,000 during the last six months of 2024. We are optimistic about the results of the work to date and expect market introduction via beta testing later in 2024, which will continue in 2025, with a sales-ready device later 2025. SpinDx™ uses a centrifugal disk with micro fluidic flow paths allowing multiple tests to be carried out on a single small sample. The SpinDx™ platform has the potential to revolutionize real-time screening for a panel of high abuse drugs, with the ability to quickly and quantitatively measure very low concentrations of drugs such as cocaine, heroin, methamphetamine, fentanyl and others. We intend to use this technology, sometimes referred to as "Lab on a Disk", to develop devices and tests that could be used at roadside, emergency rooms and in workplace testing to get a rapid and quantitative measure for a panel of such drugs of abuse. We have detected delta-9-THC (the primary psychoactive component of marijuana) down to concentrations of 5 nanograms per milliliter in our laboratory. This includes resolving the psychoactive delta-9-THC from its inactive metabolites. Resolving the psychoactive levels from metabolites is an important step in establishing impairment. We expect the initial release of the new product will consist of the SpinDx base reader unit, an oral fluid collection device and an analysis disk. We expect subsequent product releases will utilize the same SpinDx base reader and collection devices for samples from blood and from breath. We completed the upgrade of our base breathalyzer platform in 2019 (the LX9), and we remain committed to combining it with the SpinDx technology. If successful, this combination will result in a marijuana breathalyzer.
pdicamillo1
2 months ago
My gut tells me that once the SpinDx technology proves itself worthy and reliable, one of the big boys comes in and announces an acquisition/merger so we may not ever get to witness the exponential growth like we saw in Taser. If this technology performs as we have been told it will, it would be an absolute steal for a company to acquire them for $20 million, $40 million, etc. and take it to new heights under new ownership. They all know that oral fluid testing is the standard moving forward and they all know that quantitative drug testing is the future. We could even see multiple bids from a few different companies.
The key to everything is having an accurate, reliable, cost effective, easy to use drug detection device that can be used not just in the states but also worldwide.
Energy Manager
2 months ago
Yes, I have compared Lifeloc to TASR, or now known as AXON on this board before. It had a very similar structure, share price, and low float - with a product that was sold to the same market as Lifeloc's devices.. I traded TASR often back when it was under $10. Had I just invested $1,000, and let it run for ten years, I would have been tremendously rewarded. Now imagine a $10,000 investment, $20,000... 3,300% return in 10 years. Take a look at this article that shows it's exponential growth. With Lifeloc's low float, low market cap, and game changing device - in a "New America," where drugs of abuse are now become legal in most states, it is very possible that Lifeloc could see similar returns.
https://www.netcials.com/invested-1000-in-stocks-10-years-ago-nasdaq/AAXN-Axon-Enterprise-Inc/
Energy Manager
2 months ago
Oral Fluid Testing will be the test of choice for the detection of drugs of abuse. It is very important to note, that the SoToxa instrument is only a qualitative test - it does not measure impairment, whereas the Lifeloc SpinDx device will give a QUANTITATIVE reading, giving a numeric value to the level of impairment. This is a very important difference in the two devices, and gives Lifeloc a huge competitive edge...
The SoToxa instrument provides either a positive, negative, or invalid result.
β’ A positive result is reported when the oral fluid sample contains at least the
minimum cut-off amount of a drug for each specific panel.
β’ A negative result is reported when the oral fluid sample does not contain the
minimum cut-off amount of a drug for each specific panel.
β’ An invalid result is reported when there is not enough oral fluid sample to
be examined.
A positive or negative SoToxa test result by itself does not determine driver impairment. The
SoToxa instrument merely provides an officer with additional information to consider during
an investigation
pdicamillo1
2 months ago
If you look at AXON (The old Taser), it just hit a new all time high today at $350 and for the longest time it traded right around $3.00-$5.00/share.
Very similar EPS to Lifeloc where it would have earnings of $.04, $.07 ($.01), etc. Then in 2013 it breaks above $6.00 and never looks back.
The Drug Screening Market in terms of revenue was estimated to be worth $9.1 billion in 2024 and is poised to reach $19.5 billion by 2029, growing at a CAGR of 16.6% from 2024 to 2029 according to a new report by MarketsandMarkets™
The drug detection market is one of the fastest growing sectors that we have.
I don't need to convince you guys on this board but if Lifeloc can pull this off, it should experience tremendous growth similar to AXON (Taser)